MRKR

Marker Therapeutics (MRKR)

About Marker Therapeutics (MRKR)

Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.

Details

Daily high

$3.85

Daily low

$3.54

Price at open

$3.75

52 Week High

$6.16

52 Week Low

$2.44

Market cap

33.9M

Dividend yield

0.00%

Volume

39,767

Avg. volume

95,290

P/E ratio

-3.51

Marker Therapeutics News